Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance. Twelve healthy and fit young adults (men and women) will complete this study. Participants will perform experimental trials on 3 separate days (one each breathing 0%, 2%, and 4% inspired CO2-all with normal 21% oxygen). During each trial, they will perform 10 minutes of submaximal treadmill walking exercise and then complete a self-paced 2-mile treadmill run time-trial.
Participants will undergo baseline measurements of pulmonary function and maximal oxygen uptake (VO2max). They will then complete two familiarization trials, with 10 minutes of submaximal exercise (~40%VO2max) followed by a self-paced 2-mile treadmill time trial. Lastly, they will complete three experimental trials, repeating the same submaximal and time-trial exercise procedures while breathing the test gas (0%, 2%, or 4% CO2-all with normal 21% oxygen). During the experimental trials, arterialized capillary blood samples will be collected at rest breathing room air, at rest breathing the test gas, and during submaximal exercise at 40% VO2max breathing the test gas. The primary outcome is 2-mile treadmill time-trial performance. Secondary outcomes include ventilation, metabolic rate, heart rate, arterialized capillary pH/PCO2/HCO3, perceived exertion, dyspnea, leg discomfort, breathing descriptors, and headache ratings.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 4% CO2 | Experimental | Inspired gas containing 4% CO2, 21% O2, balance N2 |
|
| 2% CO2 | Experimental | Inspired gas containing 2% CO2, 21% O2, balance N2 |
|
| 0% CO2 | Sham Comparator | Inspired gas containing 0% CO2, 21% O2, balance N2 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Inspired gas | Other | Inspired gas content |
|
| Measure | Description | Time Frame |
|---|---|---|
| 2 mile self-paced treadmill time trial performance | Time to complete self-paced 2 mile treadmill time trial (min:sec) | 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Ventilation rate | Ventilation rate will be assessed using a pneumotachometer [L/min] | 30 minutes |
| Oxygen consumption | Oxygen consumption will be assessed using computerized indirect calorimetry [ml/kg/min] |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Benjamin J Ryan, Ph.D. | United States Army Research Institute of Environmental Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| USARIEM | Natick | Massachusetts | 01760 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Sep 10, 2021 | May 17, 2022 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D006935 | Hypercapnia |
| ID | Term |
|---|---|
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Randomized, single-blinded crossover design
Not provided
Not provided
Single-blinded
| 30 minutes |
| Heart rate | Heart rate will be assessed using telemetry [beats per min] | 30 minutes |
| Arterialized capillary pH | Arterialized capillary pH will be assessed using a blood gas analyzer [Unitless] | 30 minutes |
| Arterialized capillary pCO2 | Arterialized capillary pCO2 will be assessed using a blood gas analyzer [mmHg] | 30 minutes |
| Arterialized capillary HCO3 | Arterialized capillary HCO3 will be assessed using a blood gas analyzer [mEq/L] | 30 minutes |
| Rating of perceived exertion | Rating of perceived exertion will be assessed using Borg's 6-20 scale [AU] | 30 minutes |
| Dyspnea | Rating of perceived dyspnea will be assessed using Borg's 0-10 scale [AU] | 30 minutes |
| Leg discomfort | Rating of perceived leg discomfort will be assessed using Borg's 0-10 scale [AU] | 30 minutes |
| Headache | Headache will be assessed using a visual analog scale [AU] | 30 minutes |
| Breathing descriptors | Breathing descriptors will be assessed by having participants check statements that apply to their breathing (e.g., breathing out requires more effort) [unitless] | 30 minutes |